What is the VERV stock price prediction for next 2 weeks?

According to our price prediction algorithm,Verve Therapeutics, Inc. (VERV) price will be around $12.69 in the next 2 weeks. This means it will increase by 14.020664869721466 from the last closing price. This prediction may vary from other time period filters for VERV stock.

What can be the highest Possible price of VERV stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, VERV can achieve the highest price of $14.53 which is 30.522949827567743 higher than last closing price. This prediction may vary from other time period filters for VERV stock.

What can be the lowest Possible price of VERV stock in next 2 weeks?

As per the forecast and algorithmic analysis, VERV stock price can be as low as $10.83 which is -2.718827734496431 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for VERV stock.

Will VERV stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that VERV stock will gain14.020664869721466 in the next 2 weeks. This prediction may vary from other time period filters for VERV stock.

What is VERV stock last closing price?

Last closing price of VERV stock was $11.13.

What is VERV stock price prediction?

VERV stock price prediction means predicting the future closing prices of VERV stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of VERV stock in a certain time period.

How we predict VERV stock future prices?

If you are searching for VERV stock forecast, analysis or price prediction, then you might be wondering what Verve Therapeutics, Inc. (VERV) will do in the future. Our VERV price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This VERV price prediction will likely answer most of your questions.

How frequent we update VERV stock predictions?

We are updating the forecasts for the VERV stock on daily basis.

Is using ML forecasting for VERV stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for VERV stock same for all the time periods?

No, the prediction for VERV stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Verve Therapeutics, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$11.130%Since 2 Weeks

Predicted Price$12.6914.02%For 2 Weeks

Upper Predicted Price$14.5330.52%For 2 Weeks

Lower Predicted Price$10.83-2.72%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of VERV will rise by +14.02% over the next 2 Weeks and hit $12.69 by Thursday, August 7, 2025. In that time frame, VERV's share price is expected to range between $10.83 and $14.53.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Aug 7, 2025	11.88	13.84	15.80
Aug 6, 2025	12.39	14.14	16.01
Aug 5, 2025	12.20	14.12	15.89
Aug 4, 2025	11.73	13.63	15.58
Aug 1, 2025	11.74	13.71	15.67
Jul 31, 2025	11.19	13.05	14.98
Jul 30, 2025	11.56	13.35	15.31
Jul 29, 2025	11.48	13.33	15.31
Jul 28, 2025	10.89	12.84	14.75
Jul 25, 2025	11.16	12.93	14.92

VERV shares rose +0.27% in Friday, July 25, 2025's trading session, rising from a previous close of $11.10 to move at $11.13. The stock demonstrated notable intraday movement (see VERV's key stats for a full breakdown), fluctuating between $11.13 and $11.13, a 0 trading range. While recent weeks have seen some volatility, VERV has managed to secure a +0.91% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 10.29M shares changing hands, 9.6M fewer than the previous session. This amounted to $114.56M in total market activity.

Will VERV Continue Its Upward Trend?

According to analyst ratings and projections for VERV, Verve Therapeutics, Inc. shares are anticipated to increase by +29.54%, potentially reaching $15.80 per share by August 7, 2025. Short-term technical indicators currently suggest a neutral sentiment for VERV. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 13 positive trading days within the past 30 sessions. Based on the VERV stock forecast, now is a good time to buy VERV stock because its current trading price is -19.57% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on VERV covering social and institutional perspectives.

VERV Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into VERV's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 73.77% to 76.24%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 64.80%, suggests strong medium-term momentum. However, the 100-day RSI, at 57.49%, maintains a neutral outlook for the long term. Insights into VERV's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Verve Therapeutics Short-Term Forecasts

VERV Forecast For Next 5 Days

Our algorithm anticipates Verve Therapeutics (VERV) stock could hit $12.28 by Aug 22, 2025. This represents a +10.35% rise from today's price, following a +1.64% change over the past five days.

VERV Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Verve Therapeutics, Inc. (VERV) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $11.28, which would mean a +1.35% increase from the current price of $11.13. Projections for this period range from a high of $13.88 to a low of $8.87.

VERV Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Verve Therapeutics's price over the next three months point to a rise. VERV stock is expected to peak at $26.78 on Apr 21, 2026 after potentially dipping to $6.86 on Apr 13, 2026. On average, VERV is likely to trade around $20.69 in the coming 90 days.

Verve Therapeutics Stock Forecast 2025

Based on our predictive models, Verve Therapeutics (VERV) is expected to trade between $6.86 and $46.12 throughout 2026. This would result in an average price of $22.22, potentially offering investors a +99.64% return from current levels.

Verve Therapeutics, Inc. Monthly Forecast 2025–2026

August 2025

According to our latest forecast models, Verve Therapeutics, Inc. (VERV) is positioned to show a strong performance in August 2025. The price is predicted to move between $16.70 and $18.51, settling at an average of $17.69. This could translate to a +58.94% gain.

September 2025

Based on current market signals, Verve Therapeutics, Inc. is projected to trend september 2025. We forecast a trading range from $14.53 to $19.85, with a likely average price of $17.58. Investors could expect a potential return of +57.95%.

October 2025

Our predictive algorithms indicate Verve Therapeutics, Inc. stock may see a shift in October 2025. The expected range spans $16.02–$24.46, with an average target of $20.04. This represents a positive outlook and a possible gain of +80.05%.

November 2025

Analyzing established trends, Verve Therapeutics, Inc. looks set to move in November 2025. Projections place the stock between $14.96 and $23.86, averaging around $20.33. This suggests a +82.66% gain from current levels.

December 2025

Market indicators suggest Verve Therapeutics, Inc. could experience notable changes during December 2025. Prices could fluctuate within $15.26 to $23.35, with a midpoint forecast of $21.61. The stock might deliver a +94.16% gain.

January 2026

Forecasting for January 2026, models estimate that Verve Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $12.93 and $24.89, averaging $21.41. This signals a positive trajectory with potential returns around +92.36%.

February 2026

According to our latest forecast models, Verve Therapeutics, Inc. (VERV) is positioned to show a strong performance in February 2026. The price is predicted to move between $11.02 and $26.72, settling at an average of $21.15. This could translate to a +90.03% gain.

March 2026

Based on current market signals, Verve Therapeutics, Inc. is projected to trend march 2026. We forecast a trading range from $10.03 to $26.78, with a likely average price of $21.58. Investors could expect a potential return of +93.89%.

April 2026

Our predictive algorithms indicate Verve Therapeutics, Inc. stock may see a shift in April 2026. The expected range spans $6.86–$30.89, with an average target of $19.98. This represents a positive outlook and a possible gain of +79.51%.

May 2026

Analyzing established trends, Verve Therapeutics, Inc. looks set to move in May 2026. Projections place the stock between $7.47 and $30.54, averaging around $21.81. This suggests a +95.96% gain from current levels.

June 2026

Market indicators suggest Verve Therapeutics, Inc. could experience notable changes during June 2026. Prices could fluctuate within $6.89 to $33.01, with a midpoint forecast of $22.20. The stock might deliver a +99.46% gain.

July 2026

Forecasting for July 2026, models estimate that Verve Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $7.56 and $46.12, averaging $28.44. This signals a positive trajectory with potential returns around +155.53%.

VERV's history of dividends and stock splits also plays a role in long-term investor confidence.